Literature DB >> 22804337

Chromosomal translocation-negative cellular extraskeletal myxoid chondrosarcoma in an adolescent female.

Alan S Boyd1.   

Abstract

Extraskeletal myxoid chondrosarcoma (EMC) is a relatively uncommon soft tissue sarcoma that typically presents in adults of middle age and affects the proximal thigh and limb girdles. Initially believed to be a low-grade malignancy, long-term patient follow-up has shown a high incidence of local recurrence and metastatic spread. EMC is uniformly resistant to chemotherapy and radiation therapy. These tumors characteristically display fibrous septae with large aggregates of mucin populated by clusters and strands of oval cells exhibiting minimal mitotic activity. A more aggressive cellular subtype has also been defined and exhibits basaloid cells showing the immunohistochemical staining features of neuroendocrine differentiation calling into question their proposed cartilaginous lineage. Most, although not all, examples of EMC possess a unique balanced chromosomal translocation [t(9;22)(q22;q12)] between the EWSR1 and NR4A3 (previously termed TEC) genes. Pediatric and adolescent cases of EMC are rare, as only 15 have been reported and appear to follow a more aggressive clinical course. Reported herein is a case of an EMC arising in the thigh of a 15-year-old female and the first to undergo evaluation of chromosomal translocation.
Copyright © 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 22804337     DOI: 10.1111/j.1600-0560.2012.01943.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  2 in total

1.  Extraskeletal myxoid chondrosarcoma of the leg in a child: A case report.

Authors:  Ali Al Khader; Esra Nsour; Raneem Bassam Al-Zubi; Hakam Mansor Dahar Al Maadat
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

2.  Hyaline Cell-Rich Apocrine Mixed Tumor with Cytologic Atypia.

Authors:  Chika Ohata
Journal:  Dermatopathology (Basel)       Date:  2018-09-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.